| Drug Name |
Meropenem |
| Drug ID |
BADD_D01393 |
| Description |
Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.
In August 2017, a combination antibacterial therapy under the market name vabomere was approved for treatment of adult patients with complicated urinary tract infections (cUTI). Vabomere consists of meropenem and [DB12107] and is intravenously admininstered. The treatment aims to resolve infection-related symptoms and achieve negative urine culture, where the infections are proven or strongly suspected to be caused by susceptible bacteria. |
| Indications and Usage |
For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01DH02 |
| DrugBank ID |
DB00760
|
| KEGG ID |
D02222; D08185
|
| MeSH ID |
D000077731
|
| PubChem ID |
441130
|
| TTD Drug ID |
D0O5FY
|
| NDC Product Code |
81962-000; 68001-447; 55150-208; 0781-3098; 81962-001; 63323-508; 63323-507; 68083-147; 0409-1391; 70121-1453; 70594-076; 44567-400; 55150-207; 0409-1390; 0781-3000; 52946-0839; 68001-324; 44567-145; 68083-146; 0409-0222; 70121-1454; 72572-415; 72572-416; 38217-0020; 38217-0021; 68001-323; 68001-446; 70278-103; 0409-3412; 70278-104; 70594-075; 44567-401; 44567-146 |
| UNII |
FV9J3JU8B1
|
| Synonyms |
Meropenem | 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid | Merrem | Ronem | Penem | SM 7338 | SM-7338 | SM7338 |
